NEWS
New Feature!!!! University Subject Rankings in 12 branches
FOR SCIENTIST REGISTRATION FOR INSTITUTIONAL BULK REGISTRATION
FOR EDIT YOUR UNIVERSITY / INSTITUTION PAGE
Some differences of the AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
List without CERN, Statistical Data etc. Only in AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
AD
Scientific Index 2024
About Us
Methodology
Compare & Choose
Contact - FAQ
login
Login
person_add
Register
school
University Rankings
subject
University Subject Rankings
place
Country Rankings
insights
i10 Productivity Rankings
insights
Subject Rankings
format_list_numbered
Top 100 Scientists
format_list_numbered
Citation Rankings
format_quote
Top 100 Institutions
local_fire_department
Country Top Lists
Zhijian Xu (徐志建)
AD Scientific Index 2024
Others
Shanghai Institute of Materia Medica - Shanghai / China
上海药物研究所
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Zhijian Xu (徐志建)'s MOST POPULAR ARTICLES
1-)
Halogen bond: its role beyond drug–target binding affinity for drug discovery and developmentZ Xu, Z Yang, Y Liu, Y Lu, K Chen, W ZhuJournal of chemical information and modeling 54 (1), 69-78, 20142992014
2-)
Nelfinavir was predicted to be a potential inhibitor of 2019-nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free …Z Xu, C Peng, Y Shi, Z Zhu, K Mu, X Wang, W ZhuBioRxiv, 2020.01. 27.921627, 20202982020
3-)
Halogen bonding for rational drug design and new drug discoveryY Lu, Y Liu, Z Xu, H Li, H Liu, W ZhuExpert opinion on drug discovery 7 (5), 375-383, 20122722012
4-)
SARS-CoV-2 Omicron RBD shows weaker binding affinity than the currently dominant Delta variant to human ACE2L Wu, L Zhou, M Mo, T Liu, C Wu, C Gong, K Lu, L Gong, W Zhu, Z XuSignal transduction and targeted therapy 7 (1), 8, 20222212022
5-)
Utilization of halogen bond in lead optimization: a case study of rational design of potent phosphodiesterase type 5 (PDE5) inhibitorsZ Xu, Z Liu, T Chen, TT Chen, Z Wang, G Tian, J Shi, X Wang, Y Lu, X Yan, ...Journal of medicinal chemistry 54 (15), 5607-5611, 20111352011
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept